Rentokil Initial (RTO) H1 2025 earnings summary

Executive summary

• Revenue grew 3.1% year-over-year to $3.36 billion, with organic growth of 1.6% and strong free cash flow conversion at 93%.

• Adjusted operating profit declined 4.5% to $511 million, mainly due to lower North America profitability.

• The France Workwear divestment is progressing, expected to complete late Q3 or early Q4, and will enhance cash generation and focus.

• North America saw improved lead flow and customer retention, with new marketing strategies and satellite branches supporting growth.

• International segment delivered robust growth, especially in Europe, Asia, and MENAT, with strong colleague and customer retention.

Financial highlights

• Adjusted operating profit was $511 million, down 4.5% year-over-year; group operating margin at 15.2%, 120 bps lower.

• Free cash flow conversion reached 93%, exceeding the 80% guidance.

• Net debt to adjusted EBITDA stood at 2.8x, impacted by $175 million adverse FX movement.

• Interim dividend per share maintained at $0.0415.

• Adjusted EBITDA fell 3.0% to $686 million; adjusted profit before tax down 7.8% to $418 million.

Outlook and guidance

• Full-year performance expected to be in line with market expectations; guidance unchanged.

• North America expected to achieve 20%+ operating margin post-2026, with $100 million cost reduction opportunity.

• FY25 M&A spend anticipated at ~$200 million; capex excluding leases $210-220 million.

• Adjusted effective tax rate estimated at 25-26%; adjusted interest costs $200-210 million.